883TiP A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLC

Jason Chesney, T. Wise-Draper, Amod A. Sarnaik, Friedrich Graf Finckenstein, Parameswaran Hari, Madan Jagasia, Anjali Desai, A. Suzuki, Xiao Wu, Allison Betof Warner